ENGINE: a Phase III randomized placebo controlled study of...

  • Main
  • 2020 / 04
  • ENGINE: a Phase III randomized placebo controlled study of...

ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1

Nowakowski, Grzegorz S, Zhu, Jun, Zhang, Qingyuan, Brody, Joshua, Sun, Xiuhua, Maly, Joseph, Song, Yuqin, Rizvi, Syed, Song, Yongping, Lansigan, Frederick, Jing, Hongmei, Cao, Junning, Lue, Jennifer K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Future Oncology
DOI:
10.2217/fon-2020-0176
Date:
April, 2020
File:
PDF, 1.34 MB
2020
Conversion to is in progress
Conversion to is failed